Inpatient Opioid Safety Act of 2021

United States117th CongressHR-5932House of Representatives
Updated: Nov 10, 2021

Summary

Inpatient Opioid Safety Act of 2021 This bill requires hospitals, as a condition of Medicare and Medicaid participation, to use specified technology to monitor patients for opioid-induced respiratory depression for 12 hours after the administration of an opioid or until the patient is discharged, whichever is earlier, unless a health care practitioner determines before administering an opioid that such monitoring should not be used and records this determination in the patient's record.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Introduced in House

  4. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.